Core Insights - Catheter Precision, Inc. achieved significant growth in 2025, with a revenue increase of 95% year-over-year, reaching $819 thousand compared to $420 thousand in 2024 [14] - The company expanded its operations by acquiring Flyte, a regional air mobility company, which diversifies its business into aviation alongside its medical device platform [5][6] Financial Performance - For the full year 2025, the company reported a gross margin of 92.3%, up from 90.0% in 2024 [14] - The net loss for 2025 was $17.2 million, with $7.8 million being non-cash, compared to a net loss of $16.6 million in 2024, of which $7.5 million was non-cash [14] - In Q4 2025, revenue was $238 thousand, a 60% increase from $148 thousand in Q4 2024, with a gross margin of 91.6% [14] Operational Highlights - The company made strides in clinical and commercial validation, expanding its customer base and advancing commercialization efforts in Europe [2][3] - The VIVO and LockeT platforms demonstrated clinical value, with 32 new customers added and the first commercial sales of LockeT in Europe [7][8] Strategic Outlook - The acquisition of Flyte positions the company to tap into a rapidly growing market, enhancing its diversified platform across healthcare technology and regional aviation [5][6] - Management believes that the initiatives undertaken create a framework for accelerated growth and potential re-rating as execution milestones are achieved [9]

Core Viewpoint - Catheter Precision, Inc. has announced significant balance sheet improvements through new institutional capital commitments, supporting the growth of its subsidiary Flyte and its expansion strategy in the regional aviation market [1][2][3]. Group 1: Growth Strategy and Capital Support - Flyte, a newly acquired subsidiary, is positioned to execute its expansion strategy with a fully funded growth plan supported by Catheter Precision [2]. - Recent strategic financings have been completed to support the transformation of the company and the expansion of the Flyte aviation platform, which also includes funding for medical device operations [2][3]. - The company believes that with access to significant institutional capital, Flyte is uniquely positioned to expand fleet operations and enter new markets [3][10]. Group 2: Market Opportunity and Operational Foundation - The regional air mobility sector is viewed as a major growth opportunity within the aviation industry, driven by increasing demand for faster regional transportation options [11]. - Flyte aims to address the growing demand for time-efficient regional air mobility, offering premium point-to-point travel between major metropolitan regions and underserved secondary markets [5][10]. - The operational foundation of Flyte allows for rapid fleet growth and expansion into additional high-demand regional markets [6][11]. Group 3: Fleet Expansion and Infrastructure - Flyte operates a growing fleet of certified aircraft and has established route infrastructure across key regional markets [9]. - The company is focused on scaling its aviation platform infrastructure and expanding its market presence across additional regional corridors [8][9]. - The acquisition of Flyte, combined with newly secured institutional capital, provides a foundation for a focused, high-growth aviation strategy while simplifying the company's balance sheet [7][10].

Core Insights - Surf Air Mobility Inc. has appointed Shawn Pelsinger to its Board of Directors, effective October 8, 2025 [1] Company Overview - Surf Air Mobility is recognized as a leading regional air mobility platform [1] - Shawn Pelsinger currently serves as Chief Legal Officer and Chief Administrative Officer at Acrisure, a global fintech provider [1]